Conference Coverage (Retrovirus)

CTL Epitope Effort Moves Toward AIDS Vaccine

Published in Vaccine Weekly, March 1st, 1999

Bit by bit, a group of research teams are piecing together the parts of an HIV vaccine.

It is widely believed that the most effective AIDS vaccine should capable of eliciting HIV specific cytotoxic lymphocyte (CTL) responses. Unfortunately, the genetic diversity of human leukocyte antigen (HLA) alleles means that an epitope that turns on CTL for one person does nothing in another.

Thus researchers are faced with the tedious task of finding the HIV CTL epitopes for each MHC type.

"HIV is a language. It's a lexicon of words, and there are many dialects," said Ann De Groot of Brown University, Providence, Rhode Island. "We are...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1999-03-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry